DcR1 polyclonal, anti-human, mouse, rat
€484.00
In stock
SKU
253372
Catalog Nr.: 253372
Size: 0.1 mg
Isotype: Rabbit Ig
Applications: E, WB, IF
Datasheet
Request Information
Size: 0.1 mg
Isotype: Rabbit Ig
Applications: E, WB, IF
Datasheet
Request Information
Protein Family: Enzymes
Pathway and Disease: Signaling Molecules and Interaction
Description:
Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family and induces apoptosis of a variety of tumor cell lines. DR4 and DR5 are the recently identified functional receptors for TRAIL. Two decoy receptors for TRAIL have been identified and designated DcR1/TRID/TRAIL-R3/LIT and DcR2/TRAIL-R4/TRUNDD. DcR1 has extracellular TRAIL-binding domain but lacks intracellular signaling domain. It is a glycophospholipid-anchored cell surface protein. DcR1 transcripts are expressed in many normal human tissues but not in most cancer cell lines. Overexpression of DcR1 did not induce apoptosis, but attenuated TRAIL-induced apoptosis.
Alternate Names: DcR1, DcR1 (ED2), TRAIL-R3, TRID, LIT
Application Notes: E: 1:500-1:1,000; WB: 1:100-1:500; IF: 1:100-1:500
Accession No.: AAB67104
Antigen: KLH-conjugated synthetic peptide encompassing a sequence within human DcR1.
Format: Each vial contains 0.1 ml IgG in PBS pH 7.4 with 0.02% sodium azide. Antibody was purified by immunogen affinity chromatography.
Storage:
Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.
Pathway and Disease: Signaling Molecules and Interaction
Description:
Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family and induces apoptosis of a variety of tumor cell lines. DR4 and DR5 are the recently identified functional receptors for TRAIL. Two decoy receptors for TRAIL have been identified and designated DcR1/TRID/TRAIL-R3/LIT and DcR2/TRAIL-R4/TRUNDD. DcR1 has extracellular TRAIL-binding domain but lacks intracellular signaling domain. It is a glycophospholipid-anchored cell surface protein. DcR1 transcripts are expressed in many normal human tissues but not in most cancer cell lines. Overexpression of DcR1 did not induce apoptosis, but attenuated TRAIL-induced apoptosis.
Alternate Names: DcR1, DcR1 (ED2), TRAIL-R3, TRID, LIT
Application Notes: E: 1:500-1:1,000; WB: 1:100-1:500; IF: 1:100-1:500
Accession No.: AAB67104
Antigen: KLH-conjugated synthetic peptide encompassing a sequence within human DcR1.
Format: Each vial contains 0.1 ml IgG in PBS pH 7.4 with 0.02% sodium azide. Antibody was purified by immunogen affinity chromatography.
Storage:
Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.
| Is Featured? | No |
|---|
Write Your Own Review